Clinical Trial Update: Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating valganciclovir for cytomegalovirus infection in solid organ transplant patients; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Valganciclovir (Valganciclovir)

Snippet

Sponsor: Salvador Gil-Vernet | Conditions: Cytomegalovirus Infection | Phase 4 | Status: COMPLETED